Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Capture of rare circulating tumor cells from blood on bio-activated oxide surface inside microfluidic channels
Date
2018
Author
Ateş, Hatice Ceren
Metadata
Show full item record
Item Usage Stats
237
views
0
downloads
Cite This
Isolation and characterization of circulating tumor cells (CTCs) have important clinical significance in terms of prognosis and early detection of response to treatment. Moreover, downstream characterization of CTCs may help better patient stratification and therapy guidance. However, CTCs are extremely rare (~10 CTCs/1010 peripheral blood cells) and highly sensitive, and specific technology is required for their isolation. Rapidly developing microfluidic technologies offer variety of advantages in rare cell isolation including rapid, low-cost and automated sample procesing, and higher sensitivity and specificity due to their similar physical dimenions to biological cells. Many of these technologies utilize immuno-affinity based CTC capture, where anti-EpCAM antibody against epithelial cell surface biomarker is widely utilized for CTC-specific cell capture. In such applications, a proper antibody immobilization plays a crucial role for high efficiency cell capture. In this study, development and evaluation of four different surface modification approaches to immobilize anti-EpCAM on the silicon oxide surfaces was presented and the selected modification method is implemented in microfluidic channels. Cell capture efficiency and capture specificity were determined using different breast cancer cell lines as a CTC model. Selective CTC capture was demonstrated using breast cancer cells (MCF-7) spiked in buffer containing background leukocytes with cell concentration ratio of 1:104. Cell capture efficiency and specificity of 90% and 87% have been achieved, respectively, with MCF7 cells. Besides, protocols for in-channel immunofluorecent cell staining and viable cell release have been developed. Shelf life of the functionalized surfaces was also determined by inspecting the capture efficiency of microchannels weekly.
Subject Keywords
Tumors.
,
Microfluidics.
URI
http://etd.lib.metu.edu.tr/upload/12621905/index.pdf
https://hdl.handle.net/11511/27155
Collections
Graduate School of Natural and Applied Sciences, Thesis
Suggestions
OpenMETU
Core
Capture of circulating tumor cells from blood on modified gold surfaces inside the microfluidic channels
Çetin, Didem; Külah, Haluk; Department of Biomedical Engineering (2019)
Detection of circulating tumor cells (CTCs) from the bloodstream has a critical role in diagnosing and treatment of cancer. However, the number of CTCs in blood compared to other blood cells are extremely rare. In this thesis, various surface modifications strategies for detection of CTCs are studied in order to be used in the microfluidic detection systems. Functionalizing the gold surface with Self Assembled Monolayers (SAMs) used for attaching the EpCAM antibodies, which made possible to immobilize EpCAM...
Capture and release of viable CTCs in microfluidic channel
Ateş, Hatice Ceren; Şen Doğan, Begüm; Özgür, Ebru; Külah, Haluk (null; 2017-10-04)
The number of circulating tumor cells (CTCs) in blood is associated with prognosis in several types of cancer. Isolation and characterization of CTCs have important clinical significance in terms of prognosis and early detection of response to treatment. Moreover, downstream characterization of CTCs may help better patient stratification and therapy guidance. However, CTCs are extremely rare and highly sensitive and specific technology is required to isolate viable CTCs from blood cells. In this study, a su...
Examination of the dielectrophoretic spectra of MCF7 breast cancer cells and leukocytes
Çağlayan, Zeynep; Demircan Yalçın, Yağmur; Külah, Haluk (Wiley, 2020-03-01)
The detection of circulating tumor cells (CTCs) in blood is crucial to assess metastatic progression and to guide therapy. Dielectrophoresis (DEP) is a powerful cell surface marker-free method that allows intrinsic dielectric properties of suspended cells to be exploited for CTC enrichment/isolation from blood. Design of a successful DEP-based CTC enrichment/isolation system requires that the DEP response of the targeted particles should accurately be known. This paper presents a DEP spectrum method to inve...
Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington's disease
Paraskevopoulou, Foteini; Parvizi, Poorya; Senger, Gokce; Tunçbağ, Nurcan; Rosenmund, Christian; Yildirim, Ferah (2021-05-11)
Transcriptional dysregulation in Huntington's disease (HD) causes functional deficits in striatal neurons. Here, we performed Patchsequencing (Patch-seq) in an in vitro HD model to investigate the effects of mutant Huntingtin (Htt) on synaptic transmission and gene transcription in single striatal neurons. We found that expression of mutant Htt decreased the synaptic output of striatal neurons in a cell autonomous fashion and identified a number of genes whose dysregulation was correlated with physiological...
Enrichment of MCF7 breast cancer cells from leukocytes through continuous flow dielectrophoresis
Çağlayan, Zeynep; Külah, Haluk; Department of Electrical and Electronics Engineering (2018)
Circulating tumor cells (CTCs) are cancerous cells detached from a primary tumor site and enter the bloodstream, causing the development of new tumors in a secondary site. Therefore, their detection in blood is critical to assess the metastatic progression and to guide the line of the therapy. However, the rarity of CTCs in the bloodstream and the lack of suitable detection tool hinders their use as a biomarker in malignancies. Recent advances in microfluidic technologies enabled development of point-of-car...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
H. C. Ateş, “Capture of rare circulating tumor cells from blood on bio-activated oxide surface inside microfluidic channels,” M.S. - Master of Science, Middle East Technical University, 2018.